Tg Therapeutics Inc (TGTX) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Tg Therapeutics Inc   (NASDAQ: TGTX)


Tg Therapeutics Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Tg Therapeutics Inc's ROI in the third quarter of 2026?
Tg Therapeutics Inc achieved a return on average invested assets (ROI) of 8.59 % in its third quarter of 2026, this is above TGTX's average return on investment of -113.52%.
Tg Therapeutics Inc invested over the 12 months ending in its third quarter of 2026 $1,235 million

ROI fell compared to the second quarter of 2026, despite the net income growth of 612.8% from the second quarter of 2026.

Within the Healthcare sector 32 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 86 to 92.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 110.1 % 130.02 % 112.56 % 87.52 % 84.16 %
Y / Y Net Income Change TTM -76.3 % 630.24 % 1331.3 % 1543.38 % 11432.81 %
Investment (TTM) in Millions 1,332 1,371 1,335 902 861
Return On Investment (TTM) 8.59 % 39.51 % 51.02 % 64.46 % 76.12 %
TGTX's Overall Ranking # 92 # 86 # 54 # 49 #
Seq. Investment Change TTM 10.53 % 23.41 % 30.5 % 18.01 % 21.02 %
Seq. Net Income Change TTM -75.98 % -4.42 % 3.29 % -0.07 % 640.14 %
Net Income (TTM) in Millions 106 441 462 447 447

TGTX Company Profile >> Back to TGTX Roi Comparisons >> See Annual TGTX Return On Investment



Return On Investment TGTX's Ranking
Within: No.
Industry # 18
Sector # 33
Overall # 92

Return On Investment Statistics
High Average Low
75.13 %
-113.52 %
-577.22 %
(Sep 30 2025)   (Mar 31 2020)







Financial Statements
Tg Therapeutics Inc's III. Quarter Investments $ 1,332 Millions TGTX's Balance sheet
Tg Therapeutics Inc's III. Quarter Income $ 55 Millions Quarterly TGTX's Income Statement
TGTX's Income by Division See TGTX's Income by Division


TGTX Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 902 479 276 130 304
Y / Y Investment Growth 88.46 % 73.59 % 112.16 % -57.28 % -47.5 %
Net Income in Millions 447 23 13 -198 -348
Y / Y Net Income Growth 1812.41 % 84.52 % - - -
Annual Return On Investment 49.55 % 4.88 % 4.59 % -152.53 % -114.36 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 49.55 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
TGTX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for TGTX's Competitors
Subscribers only: Roi for Tg Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for TGTX's Customers

Other Ratios
TGTX's Roa TGTX's Inventory Turnover Ratio TGTX's Growth Rates TGTX's Dividend Statistics
TGTX's Profitability Ratios TGTX's Asset Turnover Ratio TGTX's Dividend Growth
TGTX's Roe TGTX's Valuation Ratios TGTX's Financial Strength Ratios TGTX's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Electromed Inc   23.41 %
Iradimed Corporation  22.98 %
Corcept Therapeutics Inc  22.08 %
Resmed Inc   21.10 %
Alector Inc   20.83 %
Chemed Corporation  20.46 %
Halozyme Therapeutics Inc   19.64 %
Pro dex Inc   19.11 %
Dexcom Inc   18.92 %
Illumina Inc   18.74 %
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Sanuwave Health Inc   16.50 %
Intuitive Surgical Inc   16.30 %
Hca Healthcare Inc   15.54 %
Kiniksa Pharmaceuticals International Plc  15.45 %
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %
3m Company  13.24 %
Alpha Pro Tech Ltd   13.18 %
Beone Medicines Ltd   13.17 %
Regeneron Pharmaceuticals Inc   13.00 %
Abbvie Inc   12.87 %
Lantheus Holdings Inc   11.96 %
Msa Safety Inc  11.78 %

Date modified: 2026-11-11T10:18:59+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.